{"input_tokens": 3584, "output_tokens": 343, "text": "This is a patient report for Amy Cripto, a 13-year-old female, who presented for a new patient visit on July 31, 2023, for medication management. \n\n**Key Findings:**\n\n* **History:** Amy has a history of depression but no prior hospitalizations.\n* **Reported symptoms:** The report lists problematic symptoms but lacks specific details, referring the reader to the psychiatric review of systems.\n* **Mental Status Exam:** Amy exhibited constricted affect, dysphoric and anxious mood, but her thought process was clear, logical, and linear. She displayed no suicidal or homicidal ideation.\n* **Diagnoses:** Amy was diagnosed with obesity, post-traumatic stress disorder (unspecified and chronic), and major depressive disorder (single episode, mild, moderate, and severe without psychotic features).\n* **Treatment Plan:** Amy was prescribed desvenlafaxine (25 mg once daily) and ibuprofen (800 mg every 6-8 hours). Patient and parent/guardian were informed about the diagnosis, medication, risks, benefits, and treatment plan.  \n* **Safety:** Patient was assessed and deemed safe regarding suicidal or homicidal ideation.\n* **Follow-up:** Amy was scheduled for a follow-up appointment in 4 weeks and instructed to contact the office for any questions or concerns.\n\n**Overall:** This patient report summarizes a new patient visit for medication management of a 13-year-old with a history of depression and potential PTSD. The report highlights the patient's current diagnoses, medication choices, and the steps taken to ensure patient safety and comprehension of the treatment plan. \n"}